These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21507707)

  • 21. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens.
    Srivastava PK
    Methods; 1997 Jun; 12(2):165-71. PubMed ID: 9184380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized neoantigen vaccines: A new approach to cancer immunotherapy.
    Aldous AR; Dong JZ
    Bioorg Med Chem; 2018 Jun; 26(10):2842-2849. PubMed ID: 29111369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in the use of dendritic cells and new adjuvants for the development of therapeutic vaccines.
    Santini SM; Belardelli F
    Stem Cells; 2003; 21(4):495-505. PubMed ID: 12832702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein and Peptide Biomaterials for Engineered Subunit Vaccines and Immunotherapeutic Applications.
    Tsoras AN; Champion JA
    Annu Rev Chem Biomol Eng; 2019 Jun; 10():337-359. PubMed ID: 31173518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational design of peptide-based tumor vaccines.
    Meng WS; Butterfield LH
    Pharm Res; 2002 Jul; 19(7):926-32. PubMed ID: 12180543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Something between the amazing functions and various morphologies of self-assembling peptides materials in the medical field.
    Liu L; Liu X; Deng H; Wu Z; Zhang J; Cen B; Xu Q; Ji A
    J Biomater Sci Polym Ed; 2014; 25(13):1331-45. PubMed ID: 25088690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunological Evaluation of Co-Assembling a Lipidated Peptide Antigen and Lipophilic Adjuvants: Self-Adjuvanting Anti-Breast-Cancer Vaccine Candidates.
    Aiga T; Manabe Y; Ito K; Chang TC; Kabayama K; Ohshima S; Kametani Y; Miura A; Furukawa H; Inaba H; Matsuura K; Fukase K
    Angew Chem Int Ed Engl; 2020 Sep; 59(40):17705-17711. PubMed ID: 32583549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-Linked Peptide Nanoclusters for Delivery of Oncofetal Antigen as a Cancer Vaccine.
    Tsoras AN; Champion JA
    Bioconjug Chem; 2018 Mar; 29(3):776-785. PubMed ID: 29436221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peptide vaccines in cancer-old concept revisited.
    Kumai T; Kobayashi H; Harabuchi Y; Celis E
    Curr Opin Immunol; 2017 Apr; 45():1-7. PubMed ID: 27940327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide-Protein Interactions: From Drug Design to Supramolecular Biomaterials.
    Caporale A; Adorinni S; Lamba D; Saviano M
    Molecules; 2021 Feb; 26(5):. PubMed ID: 33668767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poly(propylacrylic acid)-peptide nanoplexes as a platform for enhancing the immunogenicity of neoantigen cancer vaccines.
    Qiu F; Becker KW; Knight FC; Baljon JJ; Sevimli S; Shae D; Gilchuk P; Joyce S; Wilson JT
    Biomaterials; 2018 Nov; 182():82-91. PubMed ID: 30107272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational Design of T-Cell- and B-Cell-Based Therapeutic Cancer Vaccines.
    Li WH; Su JY; Li YM
    Acc Chem Res; 2022 Sep; 55(18):2660-2671. PubMed ID: 36048514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclotides as a basis for drug design.
    Craik DJ; Swedberg JE; Mylne JS; Cemazar M
    Expert Opin Drug Discov; 2012 Mar; 7(3):179-94. PubMed ID: 22468950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune peptide enhancement of peptide based vaccines.
    Rosenthal KS
    Front Biosci; 2005 Jan; 10():478-82. PubMed ID: 15574384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies as crypts of antiinfective and antitumor peptides.
    Magliani W; Conti S; Cunha RL; Travassos LR; Polonelli L
    Curr Med Chem; 2009; 16(18):2305-23. PubMed ID: 19519392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases.
    Filipczak N; Yalamarty SSK; Li X; Parveen F; Torchilin V
    Molecules; 2021 May; 26(11):. PubMed ID: 34072765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycoconjugates in cancer therapy.
    Cipolla L; Peri F; Airoldi C
    Anticancer Agents Med Chem; 2008 Jan; 8(1):92-121. PubMed ID: 18220509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties and applications of antimicrobial peptides in biodefense against biological warfare threat agents.
    Dawson RM; Liu CQ
    Crit Rev Microbiol; 2008; 34(2):89-107. PubMed ID: 18568863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leveraging the therapeutic, biological, and self-assembling potential of peptides for the treatment of viral infections.
    Monroe MK; Wang H; Anderson CF; Jia H; Flexner C; Cui H
    J Control Release; 2022 Aug; 348():1028-1049. PubMed ID: 35752254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunologic and clinical outcomes of a randomized phase II trial of two multipeptide vaccines for melanoma in the adjuvant setting.
    Slingluff CL; Petroni GR; Chianese-Bullock KA; Smolkin ME; Hibbitts S; Murphy C; Johansen N; Grosh WW; Yamshchikov GV; Neese PY; Patterson JW; Fink R; Rehm PK
    Clin Cancer Res; 2007 Nov; 13(21):6386-95. PubMed ID: 17975151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.